You've reached the limit for free Overall Ranking scores. For more information, request a demo.
See CSRHub in Action
You have a total of 10 free searches available.
| Low 0-29 | 30-39 | 40-49 | 50-59 | 60-79 | 80-100 High |
Biodel Inc. is a specialty pharmaceutical company that develops novel formulations of FDA approved therapeutics to treat endocrine disorders such as diabetes and osteoporosis. Biodel’s products are created by utilizing the company's proprietary VIAdel technology, which enables rapid delivery of drugs into the blood through various routes of administration. Biodel has developed several therapeutic candidates for the treatment of diabetes and osteoporosis.
| Ticker: | BIOD |
| ISIN: | US09064M1053 |
| Address: |
100 Saw Mill Road |
| Danbury, CT, 06810, USA | |
| Website: | Biodel Inc. |
| Phone #: | 203-7965000 |
| ESG Web Area: | Subscribers Only ? |
| Industry: | Biotechnology |
We considered many names for our site—in fact we spent our first year and a half under a different name—EkoHub. We liked “Eko” — coming from the Greek word Oikos, related to economy, ecology, and “home” or social concerns. From the beginning, we believed the word “Hub” reflected our desire to be at the center of the sustainability area, providing knowledge, harmony, and consensus among the hundreds of experts judging the ESG performance of companies.